Randomized phase III trial: a decision aid in cardiovascular prevention - risk consultation related to absolute and relative risk

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN71348772

Enrollment

1100

Registered

2006-03-02

Start date

2004-11-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease Circulatory System Cardiovascular disease

Interventions

1. Intervention: a. Advanced training (continuing education) in shared decision-making, risk calculation, risk communication and the use of decision aids b. Advanced training in ARRIBA (decision aid a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age >18 years 2. Written informed consent 3. Measurement of cholesterol

Exclusion criteria

Exclusion criteria: Insufficient mental or verbal ability

Design outcomes

Primary

Measure	Time frame
Patient's attitude towards consultation (patient's perceived assessment scale)	—

Secondary

Measure	Time frame
1. GPs: changes in prescribing behaviour and consultation related to risk status 2. Patients: cardiovascular risk status after six months	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026